Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
University of Michigan · Scleroderma Foundation · +22 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
663
total citations
- FWCI
- 52.10
- Percentile
- 100%
- References
- 44
Citations per year
Authors
24Topics & keywords
Topics
Keywords
- Medicine
- Tocilizumab
- Placebo
- Clinical endpoint
- Internal medicine
- Adverse effect
- Randomized controlled trial
- Surgery
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.